Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P990071/S068

nGEN Pump

Biosense Webster, Inc. · Decision date Dec 23, 2025

FDA DECISIONP990071/S068

What did the FDA approve?

FDA records P990071/S068 as a supplement to PMA P990071, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Dec 23, 2025.

FDA approval order statement

a software update to the TRUPULSE Generator and an update to the user manual of the nGEN Pump to facilitate automatic delivery of irrigation at 30 mL/min upon initiation of energy delivery
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Dec 23, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P990071/S068
Regulatory pathway
PMA supplement
Product code
LPB
Decision code
APPR
Decision date
Dec 23, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Cardiac ablation percutaneous catheter.

Product code
LPB
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P990071/S067 · Related supplement

    SMARTABLATE System Interface Cable (D-1303-02-S)

  2. P990071/S068 received

    Application receipt date recorded by FDA.

  3. P990071/S068 · FDA decision

    Real-Time Process

Timeline entries are records held by MedtechLedger for P990071. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P990071

Product / regulatory recordCompanyPathwayDecision dateSource
Biosense Webster, Inc.PMA supplementSep 15, 2025FDA

Explore the linked device profile

Other records with product code LPB

Product / regulatory recordCompanyPathwayDecision dateSource
Biosense Webster, Inc.PMA supplementSep 15, 2026FDA
Irvine Biomedical, Inc.PMA supplementSep 3, 2026FDA
Ampere GeneratorP040014/S051
Irvine Biomedical, Inc.PMA supplementAug 7, 2026FDA
Ampere GeneratorP960016/S094
St Jude MedicalPMA supplementAug 7, 2026FDA
Stereotaxis, Inc.PMA supplementJul 31, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biosense Webster, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
31 Technology Dr., Suite 200, Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records